VHL Alliance
VHL Alliance is a Boston-based nonprofit founded in 1993 that supports people affected by Von Hippel-Lindau disease through awareness, diagnosis, and treatment advocacy to improve patient quality of life.
- Company typePrivate
- Founded1993
- HeadquartersBoston, United States
- Headcount1–10
- GTM typeB2C
- OfferingServices
What VHL Alliance does
VHL Alliance is a nonprofit patient advocacy organization founded in 1993 and headquartered in Boston, Massachusetts. According to its self-description, the organization provides awareness, diagnosis, and treatment support aimed at improving the quality of life for people affected by Von Hippel-Lindau (VHL) disease, a rare inherited genetic disorder that predisposes patients to tumors and cysts across multiple organ systems. The organization operates with a very small team of 1-10 employees, consistent with a lean rare-disease advocacy model reliant on a core staff supplemented by volunteer medical advisors and community members.
The organization is structured as a 501(c)(3)-style nonprofit (company_type: non_profit) and operates as a private entity with no public listing. No revenue model, pricing structure, product portfolio, technology stack, or strategic initiative details were available in the scraped source content — the firm's public web properties returned only loading/verification pages during data collection. As a result, the actual breadth of programmatic offerings (patient registry, clinical trial navigation, physician education, research grants, support groups) cannot be confirmed from the input, though these are typical for organizations in this category.
The competitive context is defined by the extreme rarity of VHL (estimated prevalence of 1 in 36,000 births), which means the addressable patient population is small but highly motivated and concentrated. VHL Alliance's longevity (30+ years) and Boston location — a major US biotech and academic medical hub — are its most observable structural assets. However, the absence of disclosed financials, partnerships, leadership roster, or measurable programmatic output in the input limits any deeper operational assessment.
VHL Alliance firmographics
Firmographics- Name
- VHL Alliance
- Website
- https://vhl.org
- Company type
- Private
- Founded year
- 1993
- Headcount range
- 1–10 employees
- Short description
- VHL Alliance is a Boston-based nonprofit founded in 1993 that supports people affected by Von Hippel-Lindau disease through awareness, diagnosis, and treatment advocacy to improve patient quality of life.
- Ownership category
- akta.pro rank
VHL Alliance industry classification
Industry- Product category
- Rare Disease Patient Advocacy
- NAICS
- Social Assistance (624), Other Individual and Family Services (62419)
- SIC
- Services-Social Services (8300), Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Community Health, Health Promotion & Behavior Change (SBCC) (BPADAIAL)
Keywords
Where VHL Alliance is headquartered
LocationHeadquarters
- HQ city
- Boston
- HQ country
- United States
- HQ region
- North America
Markets served
VHL Alliance business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others
VHL Alliance product offering
Product offeringCore offering
VHL Alliance is a non-profit organization that provides awareness, diagnosis support, and treatment-related resources for individuals and families affected by Von Hippel-Lindau (VHL) disease. It works to improve the quality of life for the VHL patient community through advocacy, education, and community support. Its offerings are patient- and community-focused rather than commercial products.
Differentiator
Problem solved
Functional benefit
Products and services
- VHL Disease Awareness Programs Awareness and education services focused on Von Hippel-Lindau disease for patients, families, and the broader public. Aims to increase recognition and understanding of the rare genetic disorder.
- VHL Diagnosis Support Support resources to help patients and families navigate the diagnostic process for Von Hippel-Lindau disease. Targeted at individuals suspected of or newly affected by the condition.
- VHL Treatment Resources Treatment-related information and resources for individuals affected by Von Hippel-Lindau disease. Supports patients in accessing appropriate care and treatment options.
- Quality of Life Support for VHL Community Programs and support services aimed at improving the quality of life for people affected by Von Hippel-Lindau disease, including community and patient support resources.
Companies that use VHL Alliance
Customer profileIdeal customer profiles1 record
VHL Alliance technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
VHL Alliance competitors and assessment
Company assessmentRegional players
- VHL Canada (Canadian VHL Alliance): Canadian sister organization serving VHL patients in Canada. Comparable because it operates the same disease-specific advocacy model in a different geography and occasionally collaborates with VHL Alliance on cross-border initiatives.
Direct peers
- Genetic Alliance: Non-profit focused on transforming health through genetics and supporting condition-specific advocacy organizations. Directly comparable as it serves a similar role for genetic-condition patient communities and provides infrastructure for groups like VHL Alliance.
- Children's Tumor Foundation: Patient advocacy and research-funding non-profit focused on neurofibromatosis. Comparable as a similarly-sized rare-genetic-disease advocacy organization that combines awareness, research support, and patient services.
- Tuberous Sclerosis Alliance: Non-profit advocacy organization for tuberous sclerosis complex, another rare genetic tumor-predisposition syndrome. Closely comparable in mission, scope, and operating model to VHL Alliance.
Emerging players
- Rare Disease Foundation: Non-profit supporting patients and families affected by rare diseases through research and care programs. Comparable in advocacy mission and small-team operating profile.
Broad incumbents
- National Organization for Rare Disorders (NORD): US-based umbrella advocacy organization for the entire rare-disease community. NORD is comparable because it competes for the same donor and grant dollars and overlaps in patient advocacy for conditions like VHL.
- Patient Advocate Foundation: National non-profit providing case management and financial assistance to patients with chronic, debilitating illnesses. Comparable as it serves a similar patient-support function for those with rare and serious conditions.
Others
- National Kidney Foundation: Major US non-profit addressing kidney disease, which is clinically relevant for VHL patients who develop renal cell carcinoma and renal cysts. Comparable because it competes for similar patient-education and screening-program funding.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat2 records
Key risks4 records
Key highlights5 records
Customer concentration
VHL Alliance social profiles
Digital presenceVHL Alliance financial estimates
Financial estimateRevenue estimate
Valuation estimate
VHL Alliance leadership team
Management profileNumber of profiles
VHL Alliance funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
VHL Alliance M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about VHL Alliance
What does VHL Alliance do?
VHL Alliance is a non-profit organization that provides awareness, diagnosis support, and treatment-related resources for individuals and families affected by Von Hippel-Lindau (VHL) disease. It works to improve the quality of life for the VHL patient community through advocacy, education, and community support. Its offerings are patient- and community-focused rather than commercial products.
When was VHL Alliance founded?
VHL Alliance was founded in 1993. It employs 1 to 10 people.
Where is VHL Alliance based?
VHL Alliance is headquartered in Boston, United States, in the North America region.
Who are VHL Alliance's main competitors?
VHL Canada (Canadian VHL Alliance) is listed as a regional player. Direct peers are Genetic Alliance, Children's Tumor Foundation and Tuberous Sclerosis Alliance. Rare Disease Foundation is listed as an emerging player. Broad incumbents are National Organization for Rare Disorders (NORD) and Patient Advocate Foundation. National Kidney Foundation is listed as an others.
Does VHL Alliance have an API?
No public API is recorded for VHL Alliance.
What industry is VHL Alliance in?
VHL Alliance's product category is Rare Disease Patient Advocacy. Its primary akta.pro industry code is BPADAIAL, Community Health, Health Promotion & Behavior Change (SBCC). Its NAICS code is 624 and its SIC code is 8300.